Artificial Intelligence for the Diagnosis and Treatment of Liver Fibrosis

Nov 11 2023
Room 304/306 - Hynes Convention Center
2:30 - 4:00 PM EST

Speakers

Sonya A MacParland

Ajmera Transplant Center, University of Toronto

Maria Zitnik

Harvard University

Mary E. McCarthy Rinella

The University of Chicago

Rohit Loomba

University of California, San Diego

Jakob Nikolas Kather

University of Dresden

Description

The integration of artificial intelligence (AI) into diagnosis and treatment of liver disease is a widely discussed topic of relevance for clinical trials and future drug development. Attendees will learn a basic understanding of AI approaches in liver disease and liver fibrosis; review how AI fits into clinical trials and practice with how it can improve pathological diagnostic accuracy and staging; and provide insights into how AI and AI-based novel technologies can be used to improve therapy of liver fibrosis.

Objectives

  • Provide an understanding of AI methodology in the context of liver disease and liver fibrosis
  • Learn about AI approaches used for pathological, imaging and clinical assessment of liver fibrosis
  • Understand how AI and AI-based novel technologies can improve diagnosis and therapy of liver fibrosis